Psychoneuroendocrinology
Volume 28, Issue 1 , Pages 49-65 , January 2003

Altered glucocorticoid immunoregulation in treatment resistant depression

  • Moisés E Bauer

      Affiliations

    • Department of Microbiological Sciences, Faculdade de Biociências, Pontifícia Universidade Católica do Rio Grande do Sul, 90619-900 Porto Alegre, RS, Brazil
    • Corresponding Author InformationTel.: +55-51-3320-3000/2725; fax +55-51-3320-3612
    • ,
  • Andrew Papadopoulos

      Affiliations

    • Affective Disorders Research Unit, Alexandra House — Level 2, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, Kent BR3 3BX, UK
    • ,
  • Lucia Poon

      Affiliations

    • Affective Disorders Research Unit, Alexandra House — Level 2, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, Kent BR3 3BX, UK
    • ,
  • Paula Perks

      Affiliations

    • University Research Center in Neuroendocrinology, Dorothy Crowfoot Hodgkin Laboratories, University of Bristol, Marlborough Street, Bristol BS2 8HW, UK
    • ,
  • Stafford L Lightman

      Affiliations

    • University Research Center in Neuroendocrinology, Dorothy Crowfoot Hodgkin Laboratories, University of Bristol, Marlborough Street, Bristol BS2 8HW, UK
    • ,
  • Stuart Checkley

      Affiliations

    • Affective Disorders Research Unit, Alexandra House — Level 2, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, Kent BR3 3BX, UK
    • Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
    • ,
  • Nola Shanks

      Affiliations

    • University Research Center in Neuroendocrinology, Dorothy Crowfoot Hodgkin Laboratories, University of Bristol, Marlborough Street, Bristol BS2 8HW, UK

Received 29 October 2001 ,Revised 29 January 2002 ,Accepted 30 January 2002.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. fourth ed.. Washington DC: APA; 1994;
  2. Andreoli A, Keller S, Rabaeus M, Marin P, Bartlett J, Taban C. Depression and immunity: age, severity, and clinical course. Brain Behav. Immun. 1993;7:279–292
  3. Anisman H, Ravindran A, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthimia with typical or atypical features. Mol. Psychiat. 1999;4:182–188
  4. Bauer M., 1999. Endocrine-immune interactions in major depression, acute and chronic stress. PhD Thesis. University of Bristol, UK.
  5. Bauer M, Gauer G, Luz C, Silveira R, Nardi N, Muhlen C. Evaluation of immune parameters in depressed patients. Life Sci. 1995;57:665–674
  6. Bauer M, Vedhara K, Perks P, Wilcock G, Lightman S, Shanks N. Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J. Neuroimmun. 2000;103:84–92
  7. Bearn J, Buntwal N, Papadopoulos A, Checkley S. Salivary cortisol during opiate dependence and withdrawal. Addiction Biol. 2001;6:157–162
  8. Beck A. Depression: Clinical, Experimental and Theoretical Aspects. New York: Harper & Row; 1974;
  9. Boggs DR, Joyce RA. The hematopoietic effects of lithium. Semin. Hemat. 1983;20:129–138
  10. Bronnegard M, Stierna P, Marcus C. Glucocorticoid resistant syndromes — molecular basis and clinical presentations. J. Neuroendocrinol. 1996;8:405–415
  11. Cook N, Harris B, Walker R, Hailwood R, Jones E, Johns S, et al. Clinical utility of the dexamethasone suppression test assessed by plasma and salivary cortisol determinations. Psychiat. Res. 1986;18:143–150
  12. Cookson JC, Silverstone T, Williams S, Besser GM. Plasma cortisol levels in mania: associated clinical ratings and changes during treatment with haloperidol. Br. J. Psychiat. 1985;146:498–502
  13. De La Rocque L, Campos MM, Olej B, Castilho F, Mediano IF, Rumjanek VM. Inhibition of human LAK-cell activity by the anti-depressant trifluoperazine. Immunopharmacology. 1995;29:1–10
  14. Ebrecht M, Buske-Kirschbaum A, Hellhammer D, Kern S, Rohleder N, Walker B, et al. Tissue specificity of glucocorticoid sensitivity in healthy adults. J. Clin. Endocrinol. Metab. 2000;85:3733–3739
  15. Fuggetta MP, Alvino E, Romani L, Grohmann U, Potenza C, Giuliani A. Increase of natural killer activity of mouse lymphocytes following in vitro and in vivo treatment with lithium. Immunopharmac. Immunotoxic. 1988;10:79–91
  16. Galard R, Gallart J, Catalan R, Schwartz S, Arguello J, Castellanos J. Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST. Am. J. Psychiat. 1991;148:505–508
  17. Gold P, Goodwin F, Chrousos G. Clinical and biochemical manifestations of depression. N. Engl. J. Med. 1988;319:348–413
  18. Kirschbaum C, Hellhammer D. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994;19:313–333
  19. Kok F, Heijnen C, Bruijn J, Westenberg H, Ree J. Immunoglobulin production in vitro in major depression: a pilot study on the modulating action of endogenous cortisol. Biol. Psychiat. 1995;38:217–226
  20. Kronfol Z, House J. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiat. Scand. 1989;80:142–147
  21. Kubera M, Van Bockstaele D, Maes M. Leukocyte subsets in treatment-resistant major depression. Pol. J. Pharmac. 1999;51:547–549
  22. Kubera M, Holan V, Mathison R, Maes M. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology. 2000;25:785–797
  23. Kubera M, Simbirtsev A, Mathison R, Maes M. Effects of repeated flooxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiat. Res. 2000;96:255–266
  24. Kucharz EJ, Sierakowski S, Staite ND, Goodwin JS. Mechanism of lithium-induced augmentation of T-cell proliferation. Int. J. Immunopharmac. 1988;10:253–259
  25. Lowy M, Reder A, Gormley G, Meltzer H. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test. Biol. Psychiat. 1988;24:619–630
  26. Lowy M, Gormley G, Reder A, Meltzer H. Immune function, glucocorticoid receptor regulation, and depression. In:  Miller A editors. Depressive Disorders & Immunity. Washington, DC: American Psychiatric Press; 1989;p. 107–133
  27. Maes M, Bosmans E, Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853–858
  28. Maes M, Meester I, Verkerk R, Medts P, Wauters A, Vanhoof G, et al. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers. Psychoneuroendocrinology. 1997;22:65–78
  29. Maes M, Stevens W, Peters D, DeClerck L, Scharpe S, Bridts C. A study on the blunted natural killer cell activity in severely depressed patients. Life Sci. 1992;50:505–513
  30. Maes M, Scharpé S, Meltzer H, Bosmans E, Suy E, Calabrese J, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiat. Res. 1993;49:11–27
  31. McEwen B, Biron C, Brunson K, Bulloch K, Chambers W, Dhabhar F, et al. The role of adrenocorticosteroids as modulators of immune function in health and disease: neural endocrine and immune interactions. Brain Res. Rev. 1997;23:79–133
  32. Pariante C, Miller A. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiat. 2001;49:391–404
  33. Pariante C, Pearce B, Pisell T, Owens M, Miller A. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmac. 1997;52:571–581
  34. Pariante C, Pearce B, Pisell T, Sanshez C, Po C, Su C, et al. The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999;140:4359–4366
  35. Pedersen C, Folds J, Evans D. Dexamethasone effects on numbers of cells in lymphocyte subpopulations: changes associated with major depression and DST nonsuppression. Prog. Neuropsychopharmac. Biol. Psychiat. 1989;13:895–906
  36. Ravindran A, Griffiths J, Merali Z, Anisman H. Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features. Psychosom. Med. 1998;60:283–289
  37. Rupprecht R, Kornhuber J, Wodarz N, Göbel C, Lugauer J, Sinzger C, et al. Characterization of glucocorticoid binding capacity in human monocuclear lymphocytes: increase by metyrapone is prevented by dexamethasone pretreatment. J. Neuroendocrinol. 1990;2:803–806
  38. Rupprecht R, Wordarz N, Kornhuber J, Wild K, Schmitz B, Braner H, et al. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression. Eur. Arch. Psychiat. Clin. Neurosci. 1991;241:35–40
  39. Schleifer S, Keller S, Meyerson A. Lymphocyte function in major depressive disorder. Arch. Gen. Psychiat. 1984;41:484–486
  40. Schleifer S, Keller S, Bond R, Cohen J, Stein M. Major depression disorder and immunity: role of age, sex, severity, and hospitalization. Arch. Gen. Psychiat. 1989;46:81–87
  41. Sluyser M. Hormone resistant in cancer: the role of abnormal steroid receptors. Crit. Rev. Oncog. 1994;5:539–554
  42. Sluzewska A, Rybakowski J, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. N.Y. Acad. Sci. 1995;762:474–476
  43. Tarazona R, Gonzalez-Garcia A, Zamzami N, Marchetti P, Frechin N, Gonzalo JA, et al. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immun. 1995;154:861–870
  44. Walker R, Riad-Fahmy D, Read G. Adrenal status assessed by direct radioimmunoassay of cortisol in whole saliva or paratid saliva. Clin. Chem. 1978;24:1460–1463
  45. Wik G. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood. J. Endocrin. 1995;144:425–429
  46. Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immun. Today. 1997;18:418–424
  47. Wodarz N, Rupprecht R, Kornhuber J, Schmitz B, Wild K, Braner H, et al. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression. J. Affect. Disord. 1991;22:241–248
  48. Zaharia M, Ravindran A, Griffiths J, Merali Z, Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. J. Affect. Disord. 2000;58:1–10

PII: S0306-4530(02)00009-4

Psychoneuroendocrinology
Volume 28, Issue 1 , Pages 49-65 , January 2003

Article Tools

* Image Usage & Resolution